John Liddicoat

1.0k total citations
52 papers, 474 citations indexed

About

John Liddicoat is a scholar working on Management of Technology and Innovation, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John Liddicoat has authored 52 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Management of Technology and Innovation, 16 papers in Economics and Econometrics and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John Liddicoat's work include Intellectual Property and Patents (20 papers), Biomedical Ethics and Regulation (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). John Liddicoat is often cited by papers focused on Intellectual Property and Patents (20 papers), Biomedical Ethics and Regulation (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). John Liddicoat collaborates with scholars based in United Kingdom, United States and Australia. John Liddicoat's co-authors include Edward B. Diethrich, Michael E. De Bakey, Kathleen Liddell, H. Edward Garrett, Mateo Aboy, Michael E. DeBakey, Dianne Nicol, Alberto G. Ayala, Gene Guinn and George P. Noon and has published in prestigious journals such as Circulation, Nature Biotechnology and Annals of Surgery.

In The Last Decade

John Liddicoat

49 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Liddicoat United Kingdom 14 143 132 115 95 56 52 474
Angelika Bátorová Slovakia 22 103 0.7× 149 1.1× 83 0.7× 25 0.3× 16 0.3× 77 1.7k
Francesca Marangoni Italy 9 41 0.3× 36 0.3× 21 0.2× 64 0.7× 72 1.3× 18 577
Ferenc Kiss Hungary 12 93 0.7× 159 1.2× 36 0.3× 40 0.4× 4 0.1× 51 354
Andrea Blake Australia 6 40 0.3× 147 1.1× 82 0.7× 40 0.4× 7 0.1× 22 393
Brent T. Xia United States 15 152 1.1× 167 1.3× 8 0.1× 85 0.9× 14 0.3× 25 456
Jonathan P. Wallis United Kingdom 16 97 0.7× 62 0.5× 22 0.2× 38 0.4× 152 2.7× 33 729
Leandro Siragusa Italy 12 247 1.7× 119 0.9× 35 0.3× 83 0.9× 2 0.0× 53 507
Jenna Khan United States 10 23 0.2× 30 0.2× 19 0.2× 38 0.4× 11 0.2× 23 291
Bruno Sensi Italy 12 213 1.5× 95 0.7× 31 0.3× 88 0.9× 2 0.0× 49 490
Connie Shao United States 10 158 1.1× 41 0.3× 52 0.5× 21 0.2× 2 0.0× 36 557

Countries citing papers authored by John Liddicoat

Since Specialization
Citations

This map shows the geographic impact of John Liddicoat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Liddicoat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Liddicoat more than expected).

Fields of papers citing papers by John Liddicoat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Liddicoat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Liddicoat. The network helps show where John Liddicoat may publish in the future.

Co-authorship network of co-authors of John Liddicoat

This figure shows the co-authorship network connecting the top 25 collaborators of John Liddicoat. A scholar is included among the top collaborators of John Liddicoat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Liddicoat. John Liddicoat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liddicoat, John, Kathleen Liddell, Mateo Aboy, et al.. (2024). New Drug-Development Paradigms? Opportunities and Uncertainties with New Government Drug Repurposing Programs. SSRN Electronic Journal. 1 indexed citations
2.
Liddicoat, John, et al.. (2023). Repositioning Generic Drugs: Empirical Findings and Policy Implications. SSRN Electronic Journal. 2 indexed citations
3.
Aboy, Mateo, et al.. (2022). European patent protection for medical uses of known products and drug repurposing. Nature Biotechnology. 40(4). 465–471. 10 indexed citations
4.
Aboy, Mateo, et al.. (2021). Mapping the European patent landscape for medical uses of known products. Nature Biotechnology. 39(11). 1336–1343. 7 indexed citations
5.
Aboy, Mateo, et al.. (2020). One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?. Nature Biotechnology. 38(3). 279–283. 2 indexed citations
6.
Aboy, Mateo, Kathleen Liddell, I. Glenn Cohen, et al.. (2019). How does emerging patent case law in the US and Europe affect precision medicine?. Nature Biotechnology. 37(10). 1118–1125. 13 indexed citations
7.
Liddicoat, John, Kathleen Liddell, Stuart Hogarth, et al.. (2019). Continental drift? Do European clinical genetic testing laboratories have a patent problem?. European Journal of Human Genetics. 27(7). 997–1007. 6 indexed citations
8.
Aboy, Mateo, et al.. (2019). Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. Nature Biotechnology. 37(5). 513–518. 9 indexed citations
9.
Aboy, Mateo, et al.. (2018). Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?. Nature Biotechnology. 36(12). 1146–1149. 9 indexed citations
10.
Aboy, Mateo, et al.. (2017). After Myriad, what makes a gene patent claim 'markedly different' from nature?. Nature Biotechnology. 35(9). 820–825. 15 indexed citations
11.
Liddicoat, John, Jane Nielsen, & Dianne Nicol. (2016). Three dimensions of patent infringement: liability for creation and distribtion of CAD files. eCite Digital Repository (University of Tasmania). 1 indexed citations
12.
Aboy, Mateo, et al.. (2016). Myriad's impact on gene patents. Nature Biotechnology. 34(11). 1119–1123. 15 indexed citations
13.
Liddicoat, John, Tess Whitton, & Dianne Nicol. (2015). Are the gene-patent storm clouds dissipating? A global snapshot. Nature Biotechnology. 33(4). 347–352. 9 indexed citations
14.
Liddicoat, John & Dianne Nicol. (2013). Re-evaluating False Patent Marking in Australia. eCite Digital Repository (University of Tasmania). 1 indexed citations
15.
Nicol, Dianne, John Liddicoat, & Christine Critchley. (2013). A Role for Virtual Biotechnology Companies in Drug Discovery and Development?. Journal of Commercial Biotechnology. 19(3).
16.
Liddicoat, John, et al.. (1975). Double prosthetic aortic valve. Journal of Thoracic and Cardiovascular Surgery. 69(5). 763–766. 3 indexed citations
17.
Liddicoat, John, et al.. (1975). FRACTURED RIGHT CORONARY ARTERY. The Journal of Trauma: Injury, Infection, and Critical Care. 15(5). 456–458. 4 indexed citations
18.
Bakey, Michael E. De, Edward B. Diethrich, Gerald Glick, et al.. (1969). Human cardiac transplantation: Clinical experience. Journal of Thoracic and Cardiovascular Surgery. 58(3). 303–317. 21 indexed citations
19.
Diethrich, Edward B., et al.. (1969). An analysis of operated and nonoperated patients with documented coronary arterial disease. Journal of Thoracic and Cardiovascular Surgery. 57(1). 115–125. 11 indexed citations
20.
Bakey, Michael E. De, et al.. (1967). Abnormalities of the sinuses of Valsalva. Journal of Thoracic and Cardiovascular Surgery. 54(3). 312–332. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026